An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate.
For the treatment of severe psoriasis in adults.
Windsor Clinical Research Inc., Windsor, Ontario, Canada
Innovaderm Research Inc., Montreal, Quebec, Canada
Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz, Mainz, Rheinland-Pfalz, Germany
Universität Rostock, Rostock, Germany
Post Graduate institute Of Medical Education and Research, Chandigarh, India
Pfizer Investigational Site, Seoul, Korea, Republic of
Department of Dermatology University of Bologna, Bologna, Italy
PGIMER, Chandigarh, India
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.